ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 47 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $20,889,000 | -19.7% | 2,617,626 | +0.7% | 0.50% | -31.3% |
| Q2 2020 | $26,026,000 | +41211.1% | 2,600,000 | +33705.7% | 0.73% | +3082.6% |
| Q1 2016 | $63,000 | -25.9% | 7,691 | +9.0% | 0.02% | -17.9% |
| Q4 2015 | $85,000 | +1.2% | 7,055 | +0.4% | 0.03% | +7.7% |
| Q3 2015 | $84,000 | -77.1% | 7,028 | -64.9% | 0.03% | -75.7% |
| Q2 2015 | $367,000 | – | 20,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |